Search
for
Sort by
Research 691–720 of 1000+
- Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review
- [Hirsutism and hypertrichosis in adults: investigations and treatment].
- 7472 Estrogen Monotherapy for Testosterone Suppression in Gender Diverse Patients
- 7472 Estrogen Monotherapy for Testosterone Suppression in Gender Diverse Patients
- Hirsutism
- Faculty Opinions recommendation of Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.
- Treatment of Androgenetic Alopecia with Low Dose Oral Minoxidil Monotherapy Compared to Combination Therapy with Dutasteride or Finasteride
- CAUSES AND MANAGEMENTS OF HAIR LOSS IN WOMEN
- Female pattern alopecia: current perspectives
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Telogen Effluvium – a review of the science and current obstacles
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Skin manifestations associated with COVID-19
- Female Pattern Hair Loss
- No. 350-Hirsutism: Evaluation and Treatment
- Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
- Polycystic ovary syndrome: pragmatic management across levels of care
- Role of Topical Ketoconazole in Therapeutic Hair Care Beyond Seborrhoeic Dermatitis and Dandruff
- Synergistic Phytochemical and Pharmacological Actions of Hair RiseTM Microemulsion: A Novel Herbal Formulation for Androgenetic Alopecia and Hair Growth Stimulation
- Placental mRNA Expression of Neurokinin B Is Increased in PCOS Pregnancies with Female Offspring
- Landing Eyes on Unnoticed Disorder: A Polycystic Ovary Syndrome
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- Successful topical minoxidil treatment for hair density and length in trichorhinophalangeal syndrome type 1
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility